Response to RFI on Reporting on Pharmacy Benefits and Prescription Drug Costs

In this letter, ACHP provides recommendations to the Biden Administration on how to improve the Requirements Related to Prescription Drug Reporting executive order. ACHP calls for explore reporting requirements for drug makers and streamlining the reporting process on pharmacy benefits.

Loader Loading...
EAD Logo Taking too long?
Reload Reload document
| Open Open in new tab
icon-arrow
client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo
icon-arrow